Trials / Conditions / Recurrent Myeloproliferative Neoplasm
Recurrent Myeloproliferative Neoplasm
4 registered clinical trials studyying Recurrent Myeloproliferative Neoplasm — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Axatilimab With or Without Azacitidine for the Treatment of Patients With Advanced Phase Myeloproliferative Ne NCT06523556 | Uma Borate | Phase 1 / Phase 2 |
| Active Not Recruiting | Ivosidenib and Combination Chemotherapy for the Treatment of IDH1 Mutant Relapsed or Refractory Acute Myeloid NCT04250051 | Northwestern University | Phase 1 |
| Recruiting | Azacitidine and Quizartinib for the Treatment of Myelodysplastic Syndrome or Myelodysplastic/Myeloproliferativ NCT04493138 | M.D. Anderson Cancer Center | Phase 1 / Phase 2 |
| Terminated | Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME Trial NCT03878524 | OHSU Knight Cancer Institute | Phase 1 |